Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2007
12/05/2007CN101084014A Single domain antibodies against tnfr1 and methods of use therefor
12/05/2007CN101084013A Cancerous disease modifying antibodies
12/05/2007CN101084012A Methods of treating cancer using il-21 and monoclonal antibody therapy
12/05/2007CN101084011A Porcine reproductive and respiratory syndrome virus strains and compositions
12/05/2007CN101084010A Vaccines against japanese encephalitis virus and west nile virus
12/05/2007CN101083907A Compositions and methods for topical diagnostic and therapeutic transport
12/05/2007CN101082051A Recombined foot-and-mouth disease virus polypeptide fragment and and uses thereof
12/05/2007CN101082041A Novel vaccinia virus strain, vaccinia live attenuated vaccine and preparation method thereof
12/05/2007CN101081869A Humanized antibodies that recognize beta amyloid peptide
12/05/2007CN101081868A Humanized antibodies that recognize beta amyloid peptide
12/05/2007CN101081867A Humanized antibodies that recognize beta amyloid peptide
12/05/2007CN101081866A Domestic animal and aquatic product causal agent resistant specific IgY or compound IgY and application thereof
12/05/2007CN101081863A Lipopolysaccharide conjugated protein and monoclonal antibody and preparation method and usage
12/05/2007CN101081299A Yelk immune globulin products for preventing and treating bainite cryptosporidiosis and application thereof
12/05/2007CN101081298A Method for preparation of novel subunit vaccine for treating porcine pseudorabies
12/05/2007CN101081297A Fowl multi-killed pasteurellosis bacillus live vaccine
12/05/2007CN101081296A Method for preparing b type haemophilus influenzae capsular polysaccharide and united vaccines thereof
12/05/2007CN100352930C Vaccines immunotherapeutics and method for using the same
12/05/2007CN100352924C BASB 111 polypeptide and polynucleotide from moraxella cathraahalis
12/05/2007CN100352921C Compositions and methods for identifying antigens which elicit an immune response
12/05/2007CN100352918C Cellular immunogenicity potentiating composition containing alpha-glycosylceramide
12/05/2007CN100352844C Recombinant anti-osteopontin antibody and use thereof
12/05/2007CN100352843C Kdr peptides and vaccines comprising the same
12/05/2007CN100352513C Novel mucous membrane vaccine for newcastle disease and its construction method
12/05/2007CN100352502C Recombinant protein and recombinant gene capable of preventing and curing I type diabetes mellitus through immunity
12/05/2007CN100352501C Cripto blocking antibodies and uses thereof
12/05/2007CN100352500C Stable liquid formulations of antibodies
12/05/2007CN100352497C Antibody inhibition body fluid immunity of using special integrated CD40CR(CD40 part)
12/05/2007CN100352427C Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight
12/04/2007US7304151 Useful in vaccine effective against Mannheimia haemolytica in animals
12/04/2007US7304142 Mammalian MDM2 binding proteins
12/04/2007US7304139 Polynucleotides and polypeptides of Anaplasma phagocytophilum and methods of using the same
12/04/2007US7304135 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
12/04/2007US7303926 Causing necrosis or apoptosis of target tissue using both type 1 and type 2 mechanisms
12/04/2007US7303911 Useful as vaccine for the treatment of prostate cancer especially with a vaccine adjuvant which may include Il-2, IL-12, interferon gamma, BCG, tetanus toxoid or Mycobacterium Vaccae.
12/04/2007US7303896 Nucleic acid encoding novel type-1 cytokine receptor GLM-R
12/04/2007US7303885 For treating or detecting MIF (macrophage migration inhibitor factor) related diseases by detecting MIF/Jab1 (c-Jun activation domain binding protein) interactions; complex MIF in natural association with Jab1 and optionally another protein
12/04/2007US7303754 MVA expressing modified HIV envelope, gag, and pol genes
12/04/2007US7303752 Treating infection to increase lymphocyte proliferation with cocktail of recombinant or synthetic antigens derived from hookworm, or chemically treated hookworm; tuberculosis, malaria, measles, tetanus, diphtheria, pertussis, polio; human T-cell leukemia/lymphoma and/or lymphadenopathy associated virus
12/04/2007US7303751 P. falciparum erythrocyte binding protein-2 (EBP2) Region II (RII), used to induce an immune response to Plasmodium falciparum merozoites to treat diseases such as malaria
12/04/2007US7303750 Methods to improve immunogenicity of antigens and specificity of antibodies
12/04/2007US7303749 Immunoconjugate of a maytansine linked to a monoclonal antibody that binds to an antigen expressed by a cancer cell, and a taxane, an epothilone, a platinum compound, an epipodophyllotoxin, and/or a camptothecin
12/04/2007US7303747 Use of VEGF inhibitors for treatment of eye disorders
12/04/2007US7302913 Vaccine against salmonid rickettsial septicaemia based on arthrobacter cells
12/04/2007CA2310677C In vitro and in vivo growth-promoting proteins and peptides for kidney epithelial cells
12/04/2007CA2283295C Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels
12/04/2007CA2224724C Subunit vaccine against flavivirus infection
12/04/2007CA2201120C Polyethylene glycol modified ceramide lipids and liposome uses thereof
12/04/2007CA2140878C Interleukin-4 stimulated t lymphocyte cell death
12/04/2007CA2121241C Porcine reproductive respiratory syndrome vaccine and diagnostic
11/2007
11/29/2007WO2007137279A2 Herv-k antigens, antibodies, and methods
11/29/2007WO2007137275A2 Stimulators of osteoblastogenesis and applications of the same
11/29/2007WO2007137235A2 Apparatus, methods and systems for toxin delivery to the nasal cavity
11/29/2007WO2007137170A2 Anti-glypican-3 antibody drug conjugates
11/29/2007WO2007136882A2 Radiating element for radar array antenna
11/29/2007WO2007136778A2 Fusion proteins, uses thereof and processes for producing same
11/29/2007WO2007136679A2 Targeting vegf-b regulation of fatty acid transporters to modulate human diseases
11/29/2007WO2007136585A2 Immunotherapeutic compositions and methods
11/29/2007WO2007136525A2 Chimeric monoclonal antibody
11/29/2007WO2007135992A1 Cerebral vasospasm inhibitor
11/29/2007WO2007135546A2 TREATMENT OF CANCER WITH ANTI-IL-1α ANTIBODIES
11/29/2007WO2007135542A2 Progastrin inhibitors in the treatment of colon cancer
11/29/2007WO2007135425A1 Stable vaccine formulation
11/29/2007WO2007135401A2 Method for producing regulatory t cells by costimulating cd55 and cd3
11/29/2007WO2007135390A1 Prevention of plaque formation
11/29/2007WO2007135385A1 Chemically defined culture medium for neisseria
11/29/2007WO2007134538A1 Rat antihuman macrophage migration inhibitory factor monoclonal antibody and its application
11/29/2007WO2007134385A1 Immunogenic compositions
11/29/2007WO2007134350A2 Antibodies specific for bet v 1 and use thereof in the prevention and treatment of bet v 1-induced diseases
11/29/2007WO2007113222A3 Immunogenic composition
11/29/2007WO2007113172A3 Antibodies against amyloid-beta peptide
11/29/2007WO2007111931A3 Compositions and methods relating to modulation of immune system components
11/29/2007WO2007109823A3 Peptide library
11/29/2007WO2007106744A3 Anti-5t4 antibodies and uses thereof
11/29/2007WO2007103288A3 Engineered antibody drug conjugates
11/29/2007WO2007103112A3 Methods of treating inflammatory and autoimmune diseases with natalizumab
11/29/2007WO2007097810A3 Treatment for antiphospholipid-syndrome-related pregnancy complications
11/29/2007WO2007090872A3 Antibodies against secreted fri zzled related protein-4 (sfrp-4 )
11/29/2007WO2007084583A3 Soluble fragments of the sars-cov spike glycoprotein
11/29/2007WO2007081978A3 Modulators of hepatocyte growth factor / c-met activity
11/29/2007WO2007081966A3 Small molecules for treating cancer and abnormal cell proliferation disorders
11/29/2007WO2007081938A3 Mannheimia haemolytica chimeric outer membrane protein plpe and leukotoxin epitopes as a vaccine or vaccine component against shipping fever
11/29/2007WO2007080392A3 Ligands that have binding specificity for vegf and/or egfr and methods of use therefor
11/29/2007WO2007071710A3 Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
11/29/2007WO2007070432A3 Binding proteins specific for insulin-like growth factors and uses thereof
11/29/2007WO2007068750A3 Immunoglobulins directed against nogo
11/29/2007WO2007067992A3 Human monoclonal antibodies to fucosyl-gm1 and methods for using anti-fucosyl-gm1
11/29/2007WO2007067959A3 Ctla-4 antibody dosage escalation regimens
11/29/2007WO2007052168A3 Fed batch culture methods for streptococci
11/29/2007WO2007051036A8 Influenza combinatorial antigen vaccine
11/29/2007WO2007048107A3 Proteomic profiling of mast cell tumors and related methods, proteins and nucleic acid molecules
11/29/2007WO2007047967A3 Detoxification depot for alzheimer's disease
11/29/2007WO2007038453A3 Use of an anti-vascular endothelial growth factor (vegf) agent to ameliorate inflammation
11/29/2007WO2007022151A3 Immunization of avians by administration of non-replicating vectored vaccines
11/29/2007WO2006138745A3 Therapeutic peptides and vaccines
11/29/2007WO2006050075A3 Method of increasing efficacy of tumor cell killing using combinations of anti-neoplastic agents
11/29/2007WO2004078022A3 Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
11/29/2007WO2004037202A3 Gb virus c and methods of treating viral infections
11/29/2007US20070276037 Cytoprotective Effects of Ethyl Pyruvate
11/29/2007US20070275895 Inhibiting proliferation of immune cells in leukemia comprising administering an antibody that specifically binds a follistatin-3 polypeptide; inhibiting B cell or T cell proliferation